Philadelphia District Attorney Larry Krasner has filed a lawsuit against nearly 20 pharmaceutical companies, including some of the nation's largest, over the artificially high cost of insulin. Krasner accused the companies of colluding to raise insulin prices, describing it as a pricing scheme to inflate the drug's cost. The lawsuit aims to address what Krasner sees as profits prioritized over patients, alleging price fixing and a violation of seeking justice.